Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies
The standard treatment for resectable advanced esophageal squamous cell carcinoma is neoadjuvant chemotherapy (NAC) followed by surgery. Rehabilitation is recommended during NAC; however several adverse events often hinder its completion. This study ex...
Ryoma Haneda, E. Booka, Takahiro Kuroda et al.· Diseases of the esophagus· 0 citations
Esophageal Cancer: Adjuvant and Neo-Adjuvant Therapies
Although cisplatin-based neoadjuvant chemotherapy is the standard for resectable esophageal squamous cell carcinoma in Japan, some patients are unfit due to age, renal, or cardiac dysfunction. No established treatment option exists for cisplatin-unfit...
Y. Ishizuka, Toru Kadono, Akitoshi Hakoda et al.· Diseases of the esophagus· 0 citations
RAMIE can be safely performed for thoracic esophageal cancer and esophagogastric junction cancer, contributing to the reduction of postoperative complications without compromising curative outcomes and to evaluate the clinical utility of RAMIE.
Hirotoshi Kikuchi, Yuki Sakai, Ryoma Haneda et al.· Diseases of the esophagus· 0 citations
Robot-assisted esophagectomy may significantly reduce the incidence of recurrent laryngeal nerve palsy and is expected to further reduce postoperative complications and potentially improve long-term outcomes.
E. Booka, Takahiro Kuroda, Shuhei Yasumoto et al.· Diseases of the esophagus· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
